VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
COOThe Cooper Companies, Inc.
$65.91$12.9B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

COO logoThe Cooper Companies, Inc.(COO)Earnings, Financials & Key Ratios

COO•NASDAQ
35.2× P/E·Price updated Jun 19, 2026
SectorHealthcareIndustryMedical InstrumentsSub-IndustryDental and vision care devices
AboutThe Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.Show more
  • Revenue$4.09B+5.1%
  • EBITDA$1.11B+2.3%
  • Net Income$375M-4.4%
  • EPS (Diluted)1.87-4.6%
  • Gross Margin60.67%-9.0%
  • EBITDA Margin27.02%-2.6%
  • Operating Margin16.69%-7.9%
  • Net Margin9.16%-9.0%
  • ROE4.59%-8.5%

COO Key Insights

The Cooper Companies, Inc. (COO) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Strong 5Y sales CAGR of 11.0%
  • ✓Healthy 5Y average net margin of 28.0%

✗Weaknesses

  • ✗Weak 3Y average ROE of 4.5%

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when COO posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

COO Price & Volume

The Cooper Companies, Inc. (COO) stock price & volume — 10-year historical chart

Loading chart...

COO Growth Metrics

The Cooper Companies, Inc. (COO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years8.58%
5 Years10.98%
3 Years7.35%
TTM6.09%

Profit CAGR

10 Years6.3%
5 Years9.48%
3 Years-0.95%
TTM-43.07%

EPS CAGR

10 Years-7.64%
5 Years-17.22%
3 Years-1.22%
TTM-42.63%

Return on Capital

10 Years7.22%
5 Years5.96%
3 Years5.86%
Last Year6.05%

COO Recent Earnings

The Cooper Companies, Inc. (COO) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 8/12 qtrs (67%)
Q3 2026Latest
Jun 4, 2026
Metric
Actual
Est
EPS
$1.21+10.0%
$1.10
Rev
$1.1B+2.6%
$1.1B
Q2 2026
Mar 5, 2026
Metric
Actual
Est
EPS
$1.10+6.8%
$1.03
Rev
$1.0B+0.0%
$1.0B
Q4 2025
Dec 4, 2025
Metric
Actual
Est
EPS
$1.15+3.6%
$1.11
Rev
$1.1B+0.4%
$1.1B
Q3 2025
Aug 27, 2025
Metric
Actual
Est
EPS
$1.10+2.8%
$1.07
Rev
$1.1B-0.3%
$1.1B
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q3 2026LatestJun 4, 2026
$1.21vs $1.10+10.0%
$1.1Bvs $1.1B+2.6%
Q2 2026Mar 5, 2026
$1.10vs $1.03+6.8%
$1.0Bvs $1.0B+0.0%
Q4 2025Dec 4, 2025
$1.15vs $1.11+3.6%
$1.1Bvs $1.1B+0.4%
Q3 2025Aug 27, 2025
$1.10vs $1.07+2.8%
$1.1Bvs $1.1B-0.3%
Based on last 12 quarters of dataView full earnings history →

COO Peer Comparison

The Cooper Companies, Inc. (COO) competitors in Dental and vision care devices — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
BLCO logoBLCOBausch + Lomb CorporationDirect Competitor5.3B14.87-14.586.47%-4.21%-3.37%0.82
EW logoEWEdwards Lifesciences CorporationDirect Competitor50.37B87.3647.7411.55%17.64%10.35%0.07
HSIC logoHSICHenry Schein, Inc.Direct Competitor9.17B79.9224.444.03%3.02%8.24%0.77
HOLX logoHOLXHologic, Inc.Direct Competitor16.97B76.0130.531.74%13.18%11.01%0.52
JNJ logoJNJJohnson & JohnsonProduct Competitor550.4B228.3939.454.3%27.26%31.69%0.51
ABT logoABTAbbott LaboratoriesProduct Competitor153.68B88.3811.574.59%31.88%27.26%0.32
BSX logoBSXBoston Scientific CorporationProduct Competitor67.31B45.2923.3519.87%14.4%12.4%0.51
IDXX logoIDXXIDEXX Laboratories, Inc.Product Competitor44.64B562.0942.9710.42%24.63%70.87%0.67

Compare COO vs Peers

The Cooper Companies, Inc. (COO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs BLCO

Most directly comparable listed peer for COO.

Scale Benchmark

vs JNJ

Larger-name benchmark to compare COO against a more recognizable public peer.

Peer Set

Compare Top 5

vs BLCO, EW, HSIC, HOLX

COO Income Statement

The Cooper Companies, Inc. (COO) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricOct'17Oct'18Oct'19Oct'20Oct'21Oct'22Oct'23Oct'24Oct'25TTM
Sales/Revenue
2.14B2.53B2.65B2.43B2.92B3.31B3.59B3.9B4.09B4.23B
Revenue Growth %
8.75%18.41%4.76%-8.39%20.22%13.2%8.61%8.41%5.06%6.09%
Cost of Goods Sold
773.2M900.5M896.6M896.1M966.7M1.17B1.24B1.3B1.61B1.51B
COGS % of Revenue
36.15%35.55%33.79%36.86%33.08%35.33%34.38%33.37%39.33%-
Gross Profit
1.37B▲ 0%
1.63B▲ 19.5%
1.76B▲ 7.6%
1.53B▼ 12.6%
1.96B▲ 27.4%
2.14B▲ 9.4%
2.36B▲ 10.2%
2.6B▲ 10.1%
2.48B▼ 4.3%
2.72B▲ 0%
Gross Margin %
63.85%64.45%66.21%63.14%66.92%64.67%65.62%66.64%60.67%64.37%
Gross Profit Growth %
16.43%19.51%7.63%-12.64%27.43%9.4%10.2%10.09%-4.35%-
Operating Expenses
936.7M1.2B1.23B1.22B1.45B1.63B1.82B1.89B1.8B2.23B
OpEx % of Revenue
43.79%47.57%46.31%50.31%49.62%49.33%50.78%48.52%43.98%-
Selling, General & Admin
799.1M973.3M996.6M992.5M1.21B1.34B1.5B1.53B1.63B1.91B
SG&A % of Revenue
37.36%38.43%37.56%40.83%41.44%40.57%41.78%39.37%39.78%-
Research & Development
69.2M84.8M86.7M93.3M92.7M110.3M137.4M155.1M172.2M172.8M
R&D % of Revenue
3.24%3.35%3.27%3.84%3.17%3.33%3.82%3.98%4.21%-
Other Operating Expenses
68.4M146.7M145.8M137.2M146.1M179.5M186.2M201.2M03M
Operating Income
429.1M▲ 0%
403.1M▼ 6.1%
546.7M▲ 35.6%
311.8M▼ 43.0%
505.8M▲ 62.2%
507.6M▲ 0.4%
533.1M▲ 5.0%
705.7M▲ 32.4%
682.9M▼ 3.2%
497.9M▲ 0%
Operating Margin %
20.06%15.92%20.6%12.83%17.31%15.34%14.84%18.12%16.69%11.77%
Operating Income Growth %
32.4%-6.06%35.62%-42.97%62.22%0.36%5.02%32.38%-3.23%-
EBITDA
617.5M678.2M827.5M598.9M815.1M853.7M900.8M1.08B1.11B697M
EBITDA Margin %
28.87%26.78%31.19%24.64%27.89%25.8%25.07%27.75%27.02%16.47%
EBITDA Growth %
18.2%9.83%22.01%-27.63%36.1%4.74%5.52%19.98%2.32%-37.84%
D&A (Non-Cash Add-back)
188.4M275.1M280.8M287.1M309.3M346.1M367.7M375.1M423M193.8M
EBIT
427.4M414.6M545.4M303.3M514.6M532.6M518.2M696.6M630.4M481.2M
Net Interest Income
-33.4M-82.7M-68M-36.8M-23.1M-57.3M-105.3M-114.3M-100M-93.1M
Interest Income
0000000000
Interest Expense
33.4M82.7M68M36.8M23.1M57.3M105.3M114.3M100M93.1M
Other Income/Expense
-35.1M-71.2M-91.4M-45.3M-14.3M-32.3M-120.2M-123.4M-116.4M-85.4M
Pretax Income
394M▲ 0%
331.9M▼ 15.8%
477.4M▲ 43.8%
266.5M▼ 44.2%
491.5M▲ 84.4%
475.3M▼ 3.3%
412.9M▼ 13.1%
582.3M▲ 41.0%
566.5M▼ 2.7%
412.5M▲ 0%
Pretax Margin %
18.42%13.1%17.99%10.96%16.82%14.37%11.49%14.95%13.84%9.75%
Income Tax
21.1M192M10.7M28.1M-2.45B89.5M118.7M190M191.6M176.7M
Effective Tax Rate %
5.36%57.85%2.24%10.54%-499.13%18.83%28.75%32.63%33.82%42.84%
Net Income
372.9M▲ 0%
139.9M▼ 62.5%
466.7M▲ 233.6%
238.4M▼ 48.9%
2.94B▲ 1135.2%
385.8M▼ 86.9%
294.2M▼ 23.7%
392.3M▲ 33.3%
374.9M▼ 4.4%
235.8M▲ 0%
Net Margin %
17.43%5.52%17.59%9.81%100.76%11.66%8.19%10.07%9.16%5.57%
Net Income Growth %
36.14%-62.48%233.6%-48.92%1135.19%-86.9%-23.74%33.34%-4.44%-43.07%
Net Income (Continuing)
372.9M139.9M466.7M238.4M2.94B385.8M294.2M392.3M374.9M235.8M
Discontinued Operations
0000000000
Minority Interest
100K200K200K200K200K200K200K200K200K200K
EPS (Diluted)
7.52▲ 0%
2.81▼ 62.6%
9.32▲ 231.7%
4.81▼ 48.4%
59.07▲ 1128.1%
1.94▼ 96.7%
1.48▼ 23.7%
1.96▲ 32.4%
1.87▼ 4.6%
1.21▲ 0%
EPS Growth %
34.53%-62.63%231.67%-48.39%1128.07%-96.72%-23.71%32.43%-4.59%-42.63%
EPS (Basic)
7.632.859.474.8659.731.961.491.971.88-
Diluted Shares Outstanding
198.4M198.8M200.2M198.2M199.4M198.8M199.2M200.4M200M195M
Basic Shares Outstanding
195.6M196.4M197.2M196.4M197.2M197.2M198M198.9M200M195M
Dividend Payout Ratio
0.78%2.07%0.64%1.26%0.1%0.78%1.02%---

COO Balance Sheet

The Cooper Companies, Inc. (COO) balance sheet — assets, liabilities & shareholders' equity

MetricOct'17Oct'18Oct'19Oct'20Oct'21Oct'22Oct'23Oct'24Oct'25TTM
Total Current Assets
953.2M1.09B1.16B1.27B1.47B1.53B1.7B1.95B2.11B2.3B
Cash & Short-Term Investments
88.8M77.7M89M115.9M95.9M138.2M120.8M107.6M110.6M138.8M
Cash Only
88.8M77.7M89M115.9M95.9M138.2M120.8M107.6M110.6M138.8M
Short-Term Investments
0000000000
Accounts Receivable
316.6M374.7M435.3M435.4M515.3M557.8M609.7M717M829M809.2M
Days Sales Outstanding
54.025459.8865.3864.3661.5461.9367.1873.9469.82
Inventory
454.1M468.8M506.9M570.4M585.6M628.7M735.6M802.7M846M896.4M
Days Inventory Outstanding
214.36190.02206.36232.34221.11196.33217.35225.43191.85211.85
Other Current Assets
000089.2M0238.8M324.2M320.8M455.4M
Total Non-Current Assets
3.91B5.02B5.11B5.46B8.14B9.96B9.95B10.36B10.29B10.18B
Property, Plant & Equipment
910.1M976M1.13B1.54B1.35B1.43B1.63B1.86B2.08B2.13B
Fixed Asset Turnover
2.35x2.60x2.34x1.58x2.17x2.31x2.20x2.09x1.97x2.03x
Goodwill
2.35B2.39B2.43B2.45B2.57B3.61B3.62B3.84B3.85B3.89B
Intangible Assets
504.7M1.52B1.41B1.29B1.27B1.89B1.71B1.79B1.59B1.49B
Long-Term Investments
0000000000
Other Non-Current Assets
75.6M74.1M66.8M104.8M401.2M587.9M637.1M660.6M689.2M672.8M
Total Assets
4.86B▲ 0%
6.11B▲ 25.8%
6.27B▲ 2.6%
6.74B▲ 7.4%
9.61B▲ 42.6%
11.49B▲ 19.6%
11.66B▲ 1.4%
12.32B▲ 5.6%
12.39B▲ 0.6%
12.48B▲ 0%
Asset Turnover
0.44x0.41x0.42x0.36x0.30x0.29x0.31x0.32x0.33x0.34x
Asset Growth %
8.55%25.81%2.65%7.38%42.58%19.63%1.45%5.63%0.65%5.07%
Total Current Liabilities
396.1M536.5M1.11B1B732.1M1.28B969M1.02B1.11B1.8B
Accounts Payable
142.1M146.4M150.1M176M161.4M248.8M261.9M260.5M300.4M233.3M
Days Payables Outstanding
67.0859.3461.171.6960.9477.777.3873.1668.1261.46
Short-Term Debt
23.4M37.1M563.7M409.3M82.9M395.7M44.4M32.2M85.6M598.9M
Deferred Revenue (Current)
000019M93.6M123.6M129.9M127.9M512.3M
Other Current Liabilities
230.6M353M396.8M385.8M468.3M525.2M538.1M599.1M387.6M678.7M
Current Ratio
2.41x2.03x1.05x1.27x2.00x1.20x1.76x1.91x1.89x1.27x
Quick Ratio
1.26x1.16x0.59x0.70x1.20x0.71x1.00x1.12x1.13x0.78x
Cash Conversion Cycle
201.31184.68205.13226.02224.52180.18201.9219.45197.67220.21
Total Non-Current Liabilities
1.29B2.27B1.54B1.91B1.93B3.04B3.14B3.21B3.04B2.44B
Long-Term Debt
1.15B1.99B1.26B1.38B1.4B2.35B2.52B2.55B2.46B1.86B
Capital Lease Obligations
000236.8M1.5M3.7M3.4M2.4M242.3M247.7M
Deferred Tax Liabilities
38.8M31M28M25.8M24.1M149.9M101.5M96M93.3M387.8M
Other Non-Current Liabilities
98.7M251.8M244.7M261.8M510.3M338.4M329.4M369.1M49.8M272M
Total Liabilities
1.68B2.81B2.65B2.91B2.66B4.32B4.11B4.23B4.16B4.24B
Total Debt
1.17B2.02B1.83B2.06B1.48B2.76B2.57B2.58B2.78B2.46B
Net Debt
1.08B1.95B1.74B1.95B1.39B2.63B2.45B2.48B2.67B2.32B
Debt / Equity
0.37x0.61x0.50x0.54x0.21x0.39x0.34x0.32x0.34x0.30x
Debt / EBITDA
1.90x2.98x2.21x3.45x1.82x3.24x2.85x2.39x2.52x3.53x
Net Debt / EBITDA
1.76x2.87x2.10x3.25x1.70x3.08x2.72x2.29x2.42x3.33x
Interest Coverage
12.80x5.01x8.02x8.24x22.28x9.29x4.92x6.09x6.30x5.17x
Total Equity
3.18B▲ 0%
3.31B▲ 4.2%
3.63B▲ 9.7%
3.82B▲ 5.4%
6.94B▲ 81.5%
7.17B▲ 3.4%
7.55B▲ 5.2%
8.08B▲ 7.1%
8.24B▲ 1.9%
8.24B▲ 0%
Equity Growth %
17.8%4.16%9.7%5.41%81.5%3.35%5.24%7.05%1.92%9.64%
Book Value per Share
16.0116.6418.1219.3034.8136.0937.9140.3441.2042.25
Total Shareholders' Equity
3.18B3.31B3.63B3.82B6.94B7.17B7.55B8.08B8.24B8.24B
Common Stock
5.2M5.3M5.3M5.3M5.4M5.4M21.6M21.7M21.8M21.8M
Retained Earnings
2.43B2.58B3.03B3.26B6.2B6.58B6.88B7.27B7.64B7.7B
Treasury Stock
-415.1M-415.1M-571.2M-617.3M-639.6M-714.5M-710.3M-706M-995.2M-1.1B
Accumulated OCI
-375.3M-430.7M-447.1M-472M-341.3M-466.8M-453.8M-421.7M-406.5M-363.2M
Minority Interest
100K200K200K200K200K200K200K200K200K200K

COO Cash Flow Statement

The Cooper Companies, Inc. (COO) cash flow — operating, investing & free cash flow history

MetricOct'17Oct'18Oct'19Oct'20Oct'21Oct'22Oct'23Oct'24Oct'25TTM
Cash from Operations
593.6M668.9M713.2M486.6M738.6M692.4M607.5M709.3M796.1M953M
Operating CF Margin %
27.75%26.41%26.88%20.02%25.27%20.93%16.91%18.21%19.45%-
Operating CF Growth %
16.48%12.69%6.62%-31.77%51.79%-6.26%-12.26%16.76%12.24%145.35%
Net Income
372.9M139.9M466.7M238.4M2.94B385.8M294.2M392.3M374.9M235.8M
Depreciation & Amortization
188.4M275.1M280.8M319.6M341.1M378.3M407.7M413.8M423M384.7M
Stock-Based Compensation
37.2M43.2M35.1M0000000
Deferred Taxes
-7.1M2.9M-15.9M-900K-2.5B53.9M44.7M118.9M135.2M144M
Other Non-Cash Items
8.4M88.2M-13.4M55.3M104.9M48.4M79.7M118M147.8M176.6M
Working Capital Changes
-6.2M119.6M-40.1M-125.8M-149.9M-174M-218.8M-333.7M-284.8M11.9M
Change in Receivables
-25.1M-59.5M-55.6M8.5M-75.5M-33.8M-60.2M-117.1M-120.3M0
Change in Inventory
-30.9M-5M-37.3M-62.3M-9.2M-40.4M-105.4M-59.3M-46M0
Change in Payables
25M2.9M3.6M23.2M-16M49.9M5.5M9.3M8M0
Cash from Investing
-381.3M-1.52B-351.3M-364.5M-450.3M-1.83B-449M-764.6M-372.9M-389.8M
Capital Expenditures
-127.2M-193.6M-292.1M-310.4M-214.4M-242M-392.5M-421.2M-362.4M-383.5M
CapEx % of Revenue
5.95%7.64%11.01%12.77%7.34%7.31%10.92%10.81%8.86%9.06%
Acquisitions
00000-1.59B-56.5M-343.4M-10.5M-4.4M
Investments
----------
Other Investing
-254.1M-1.32B-59.2M-54.1M-235.9M0000-1.9M
Cash from Financing
-227.9M844.4M-351.4M-95.5M-311.4M1.19B-173.9M39.2M-425.9M-544.4M
Debt Issued (Net)
-162.5M845.7M-200.1M-42.7M-309.9M1.28B-180.8M5.6M-79.9M-145M
Equity Issued (Net)
-55M0-148.3M-31.6M1.5M-62.4M23M63.9M-274.1M-341.8M
Dividends Paid
-2.9M-2.9M-3M-3M-3M-3M-3M000
Share Repurchases
-55M0-156.1M-47.8M-24.8M-78.5M00-290.1M-265M
Other Financing
-7.5M1.6M0-18.2M0-19.7M-13.1M-30.3M-71.9M-57.6M
Net Change in Cash
-12M▲ 0%
-11.1M▲ 7.5%
11.8M▲ 206.3%
27.3M▲ 131.4%
-20.5M▼ 175.1%
42.3M▲ 306.3%
-17.7M▼ 141.8%
-13.2M▲ 25.4%
2.9M▲ 122.0%
22.7M▲ 0%
Free Cash Flow
466.4M▲ 0%
475.3M▲ 1.9%
421.1M▼ 11.4%
176.2M▼ 58.2%
524.2M▲ 197.5%
450.4M▼ 14.1%
215M▼ 52.3%
288.1M▲ 34.0%
433.7M▲ 50.5%
569.5M▲ 0%
FCF Margin %
21.8%18.77%15.87%7.25%17.94%13.61%5.98%7.4%10.6%13.46%
FCF Growth %
30.65%1.91%-11.4%-58.16%197.5%-14.08%-52.26%34%50.54%55.64%
FCF per Share
2.352.392.100.892.632.271.081.442.172.92
FCF Conversion (FCF/Net Income)
1.59x4.78x1.53x2.04x0.25x1.79x2.06x1.81x2.12x2.42x
Interest Paid
31.3M82.1M75.3M46.5M28.4M49.1M117.5M134.8M115.1M0
Taxes Paid
15.6M18.8M39.2M51.1M63.2M66.6M67.8M78.4M100M0

COO Key Ratios

The Cooper Companies, Inc. (COO) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
12.7%4.32%13.46%6.4%54.7%5.47%4%5.02%4.59%2.84%
Return on Invested Capital (ROIC)
7.86%6.36%7.72%4.2%5.38%4.2%4.04%5.15%4.77%3.48%
Gross Margin
63.85%64.45%66.21%63.14%66.92%64.67%65.62%66.64%60.67%64.37%
Net Margin
17.43%5.52%17.59%9.81%100.76%11.66%8.19%10.07%9.16%5.57%
Debt / Equity
0.37x0.61x0.50x0.54x0.21x0.39x0.34x0.32x0.34x0.30x
Interest Coverage
12.80x5.01x8.02x8.24x22.28x9.29x4.92x6.09x6.30x5.17x
FCF Conversion
1.59x4.78x1.53x2.04x0.25x1.79x2.06x1.81x2.12x2.42x
Revenue Growth
8.75%18.41%4.76%-8.39%20.22%13.2%8.61%8.41%5.06%6.09%
Related:COO Dividend History·COO Revenue History·COO Price History·COO P/E History·COO Financial Ratios·COO Institutional Holders

COO SEC Filings & Documents

The Cooper Companies, Inc. (COO) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Jun 4, 2026·SEC

Material company update

May 4, 2026·SEC

Material company update

Apr 8, 2026·SEC

10-K Annual Reports

4
FY 2025

Dec 5, 2025·SEC

FY 2024

Dec 6, 2024·SEC

FY 2023

Dec 8, 2023·SEC

10-Q Quarterly Reports

6
FY 2026

Jun 5, 2026·SEC

FY 2026

Mar 6, 2026·SEC

FY 2025

Aug 28, 2025·SEC

COO Frequently Asked Questions

The Cooper Companies, Inc. (COO) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

The Cooper Companies, Inc. (COO) reported $4.23B in revenue for fiscal year 2025. This represents a 3778% increase from $109.1M in 1996.

The Cooper Companies, Inc. (COO) grew revenue by 5.1% over the past year. This is steady growth.

Yes, The Cooper Companies, Inc. (COO) is profitable, generating $235.8M in net income for fiscal year 2025 (9.2% net margin).

Dividend & Returns

The Cooper Companies, Inc. (COO) has a return on equity (ROE) of 4.6%. This is below average, suggesting room for improvement.

The Cooper Companies, Inc. (COO) generated $569.5M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in COO back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →

How much would $100/month in COO be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →